Assign Drug Industries Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 1.00 M
as on 10-12-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2020)
- Ebitda
- Net Worth -25.64%
(FY 2020)
- Total Assets 33.45%
(FY 2020)
About Assign Drug Industries
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Shyam Singh and Roli Singh serve as directors at the Company.
- CIN/LLPIN
U74999UP2018PTC108269
- Company No.
108269
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Sep 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Assign Drug Industries?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Roli Singh  | Director | 21-Sep-2018 | Current |
| Shyam Singh | Director | 21-Sep-2018 | Current |
Financial Performance of Assign Drug Industries.
Assign Drug Industries Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 25.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Assign Drug Industries?
Unlock access to Assign Drug Industries's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Assign Technology Private LimitedActive 5 years 28 daysShyam Singh and Roli Singh are mutual person
Rs Harvesting Producer Company LimitedActive 9 years 4 monthsShyam Singh and Roli Singh are mutual person
- Assign Media Networks Private LimitedActive 5 years 10 months
Shyam Singh and Roli Singh are mutual person
- Assign Healthcare Private LimitedActive 2 years 7 months
Shyam Singh and Roli Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Assign Drug Industries?
Unlock and access historical data on people associated with Assign Drug Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Assign Drug Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Assign Drug Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
